Yongchun Zhou
Overview
Explore the profile of Yongchun Zhou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
116
Citations
1074
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peng Y, Liao J, He X, Zhou Y, Zhang L, Jia Y, et al.
Eur J Cancer Prev
. 2024 Nov;
PMID: 39513675
Carriers with germline breast cancer 1/2 gene mutations (BRCAm) are likely to develop ovarian cancer (OC). Therefore, identifying these mutations may enable individualized therapy for OC and preventive measures to...
2.
Wei X, Liao J, Lei Y, Li M, Zhao G, Zhou Y, et al.
Transl Cancer Res
. 2024 Oct;
13(9):5161.
PMID: 39430829
[This retracts the article DOI: 10.21037/tcr-20-2450.].
3.
Zhou Y, Zhao Z, Li D, Wang Y, Yang J, Han W, et al.
Sci Total Environ
. 2024 Oct;
955:176914.
PMID: 39414041
Biochar addition is effective in reducing soil greenhouse gas (GHG) emissions, but it's essential to evaluate whether aged biochar retains this capability as its properties change over time. However, research...
4.
Wang L, Guan C, Zhang T, Zhou Y, Liu Y, Hu J, et al.
J Orthop Translat
. 2024 Jul;
47:87-96.
PMID: 39007033
Background: Bone marrow mesenchymal stem cells (BMSCs) have immense potential in applications for the enhancement of tendon-bone (T-B) healing. Recently, it has been well-reported that skeletal stem cells (SSCs) could...
5.
Wang X, Zhou Q, Yang W, Bi H, Wang H, Wang Y, et al.
Hematology
. 2024 Jul;
29(1):2372482.
PMID: 38994874
Background: CD83 are closely related to the pathogenesis of immune thrombocytopenia (ITP), but the exact mechanism remains unclear. Aim: To explore the relationship between CD83 and CD4 T cell subsets...
6.
Zhou Y, Wang S, Dai J, Luo J, Cheng Q
Micromachines (Basel)
. 2024 May;
15(5).
PMID: 38793174
In this paper, a novel wideband power amplifier (PA) operating in the 2-6 GHz frequency range is presented. The proposed PA design utilizes a combination technique consisting of a distributed...
7.
Hu S, Wang J, Cui Z, Zhou Y, Gao D
BMC Cardiovasc Disord
. 2024 May;
24(1):269.
PMID: 38778265
Introduction: Surgery remains the primary treatment modality for thymic carcinoma, with adjuvant radiotherapy being recommended to effectively mitigate local recurrence and metastasis rates subsequent to incomplete or complete resection. Chemoradiotherapy...
8.
Yuan G, Chen Y, Li L, Wang X, Wei G, Zeng J, et al.
Int J Clin Pract
. 2024 Mar;
2024:1386980.
PMID: 38481823
Background: Tenapanor is a locally acting selective sodium-hydrogen exchanger 3 inhibitor with the potential to treat sodium/phosphorus and fluid overload in various cardiac-renal diseases, which has been approved for constipation-predominant...
9.
Lan Y, Tao W, Ma L, Wang X, Li H, Du Y, et al.
BMC Med Genomics
. 2024 Mar;
17(1):74.
PMID: 38468267
Background: Peripheral T-cell lymphoma (PTCL) is a subtype of non-Hodgkin's lymphoma that occurs primarily at extranodal sites and is commonly treated using chemotherapy and radiotherapy. PTCL is more malignant than...
10.
Gan L, Xing L, Xu Y, Zhou L, Jiang H, Sun X, et al.
Clin Kidney J
. 2024 Jan;
17(1):sfad216.
PMID: 38186905
Background: The efficacy and safety of tenapanor has not been confirmed in Chinese end-stage renal disease (ESRD) patients with hyperphosphatemia on haemodialysis (HD). Methods: This was a randomised, double blind,...